Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT(2A) receptors

European Journal of Pharmacology

Volumn 334, Issue 1, 1997, Pages 25-29

  Chaouloff, Francis ^a   Kulikov, Alexander ^a,b   Mormède, Pierre ^a  

^a INSERM   (France)

^b INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

5 HT(2A) receptors; Anxiety; DOI (1 (2,5 dimethoxy 4 iodophenyl) 2 aminopropane; Elevated plus maze; RHA and RLA (Roman high and low avoidance) rats; SR 46349B; 3H ketanserin binding

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; EPLIVANSERIN; SEROTONIN 2 AGONIST; SEROTONIN 2 ANTAGONIST; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BRAIN CORTEX; CONTROLLED STUDY; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMPHETAMINES; ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BODY WEIGHT; CEREBRAL CORTEX; FEMALE; FLUOROBENZENES; KETANSERIN; MALE; MAZE LEARNING; PHENOLS; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030776330     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01197-7     Document Type: Article

References (20)

1. 2 Receptor subtypes: a family re-united? Trends Pharmacol. Sci. 16:1995;105-110.
2. 2 receptor down-regulation results in anxiolytic effects in the elevated plus-maze. Drug Dev. Res. 26:1992;287-297.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein-dye binding. Analyt. Biochem. 72:1976;248-254.
4. Ceulemans D.L.S., Hoppenbrouwers M.L.J.A., Gelders Y.G., Reyntjens A.J.M. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo controlled study versus lorazepam. Pharmacopsychiatry. 18:1985;303-305.
5. 2 receptor down-regulation. Eur. J. Pharmacol. 249:1993;117-120.
6. Freo U., Halloway H.W., Greig N.H., Soncrant T.H. Chronic treatment with meta-chlorophenylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin. Psychopharmacology. 107:1992;30-38.
7. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmac. Ther. 65:1995;319-395.
8. 1C Receptors and their therapeutic relevance. Curr. Opini. Invest. Drugs. 2:1993;317-362.
9. 1C receptor antagonists. Eur. J. Pharmacol. 164:1989;445-454.
10. 2B receptor antagonist with anxiolytic-like properties. Br. J. Pharmacol. 117:1996;427-434.
11. 2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety. Psychopharmacology. 121:1995;385-395.
12. 2 antagonists: ritanserin and setoperone. Psychopharmacology. 88:1986;434-444.
13. 2 receptors in rat brain. Neuropsychopharmacology. 2:1989;81-87.
14. Onaivi E.S., Bishop-Robinson C., Darmani N.A., Sanders-Bush E. Behavioral effects of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test. Life Sci. 57:1995;2455-2466.
15. Ramos A., Berton O., Mormède P., Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav. Brain Res. 85:1997;57-69.
16. 2 receptor antagonist. J. Pharmacol. Exp. Ther. 262:1992;759-768.
17. 2 receptors in mouse brain. Mol. Pharmacol. 43:1993;84-89.
18. 2 receptor antagonist. Eur. J. Pharmacol. 246:1993;73-80.
19. 2C receptor gene inactivation. J. Psychopharmacol. 10 (Suppl. 3), abst. 223.
20. Wright I.K., Heaton M., Upton N., Marsden C.A. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze. Psychopharmacology. 107:1992;405-414.